PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+10.75%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.81B
AUM Growth
+$258M
(+7.3%)
Cap. Flow
-$47.5M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
49.66%
Holding
154
New
23
Increased
21
Reduced
32
Closed
26
Top Buys
| 1 |
Verrica Pharmaceuticals
VRCA
|
$67.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$55.8M |
| 3 |
MeiraGTx Holdings
MGTX
|
$53.9M |
| 4 |
Intuitive Surgical
ISRG
|
$43.1M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$33.7M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$121M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$50.9M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$34.2M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$30.9M |
| 5 |
AnaptysBio
ANAB
|
$24.7M |
Sector Composition
| 1 | Healthcare | 92.89% |
| 2 | Industrials | 0.65% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humana
HUM
$37.1B
| $44.1M | 1.16% |
148,218
+87,500
| +144% | +$26M |
|
27
CytomX Therapeutics
CTMX
$336M
| $43.9M | 1.15% |
1,921,715
-287,097
| -13% | -$6.56M |
|
28
argenx
ARGX
$45.2B
| $43.9M | 1.15% |
529,560
-7,801
| -1% | -$646K |
|
|
DBVT
29
DBV Technologies
DBVT
$255M
| $40.7M | 1.07% |
210,820
+1,470
| +0.7% | +$284K |
|
30
Xencor
XNCR
$583M
| $39.5M | 1.04% |
1,068,095
-250,000
| -19% | -$9.25M |
|
|
CBAY
31
DELISTED
Cymabay Therapeutics
CBAY
| $36.8M | 0.97% |
2,742,821
-60,000
| -2% | -$805K |
|
|
ARNA
32
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $36.7M | 0.96% |
841,978
+670,000
| +390% | +$29.2M |
|
|
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $35.2M | 0.92% |
713,191
+684,100
| +2,352% | +$33.7M |
|
34
ADMA Biologics
ADMA
$3.98B
| $29.4M | 0.77% |
6,521,102
+2,700,000
| +71% | +$12.2M |
|
|
ADMS
35
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $28M | 0.73% |
1,084,159
+454,159
| +72% | +$11.7M |
|
36
Puma Biotechnology
PBYI
$254M
| $27.7M | 0.73% |
564,579
+122,400
| +28% | +$6M |
|
|
VBIV
37
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $26.6M | 0.7% |
322,195
| – | – |
|
|
ECYT
38
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $26.5M | 0.7% |
1,921,700
-280,000
| -13% | -$3.86M |
|
|
BOLD
39
DELISTED
Audentes Therapeutics, Inc
BOLD
| $25.2M | 0.66% |
660,406
-95,809
| -13% | -$3.66M |
|
40
Rhythm Pharmaceuticals
RYTM
$6.92B
| $25M | 0.66% |
800,686
+208,400
| +35% | +$6.51M |
|
41
iRhythm Technologies
IRTC
$5.74B
| $25M | 0.66% |
308,006
-111,700
| -27% | -$9.06M |
|
42
Aldeyra Therapeutics
ALDX
$351M
| $24.5M | 0.64% |
3,085,458
| – | – |
|
|
ATHN
43
DELISTED
Athenahealth, Inc.
ATHN
| $23.9M | 0.63% |
+150,000
| New | +$23.9M |
|
|
ONCT
44
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $23M | 0.6% |
+10,725
| New | +$23M |
|
45
Akebia Therapeutics
AKBA
$817M
| $22.1M | 0.58% |
2,215,400
-247,000
| -10% | -$2.47M |
|
|
NEPT
46
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $20.4M | 0.53% |
6,124
| – | – |
|
|
MOTS
47
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $20.2M | 0.53% |
9,368
| – | – |
|
48
Zymeworks
ZYME
$1.09B
| $15.9M | 0.42% |
1,123,890
+430,000
| +62% | +$6.09M |
|
|
ABMD
49
DELISTED
Abiomed Inc
ABMD
| $15M | 0.39% |
36,646
-295,803
| -89% | -$121M |
|
|
NVTA
50
DELISTED
Invitae Corporation
NVTA
| $14.9M | 0.39% |
2,021,100
+170,000
| +9% | +$1.25M |
|